The Australian Centre for RNA Therapeutics in Cancer (ACRTC) is a research centre hosted at the University of Western Australia (UWA) in Perth. We aim to bring together multidisciplinary groups involving RNA technologists, oncologists, consumers, and patients advocates to design, synthesise, test and improve RNA drugs; and tackle aggressive and hard to treat cancers as use cases to develop RNA drugs and platform approaches to treating cancers.
The Centre also includes the RNA Innovation Foundry (RIF): a dedicated mRNA production facility with a focus on automated high-throughput production of mRNA for preclinical experiments.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 35 Stirling Hwy, Perth,western Australia,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- RNA, mRNA, Cancer research.
- HQ
- Perth, Western Australia
Australian Centre For Rna Therapeutics In Cancer Questions
Australian Centre For Rna Therapeutics In Cancer's website is https://www.uwa.edu.au/australian-centre-for-rna-therapeutics-in-cancer
Australian Centre For Rna Therapeutics In Cancer's LinkedIn profile is https://au.linkedin.com/company/acrtc
Australian Centre For Rna Therapeutics In Cancer has
2 employees.
View email and phone details for 2
employees at Australian Centre For Rna Therapeutics In Cancer.
Australian Centre For Rna Therapeutics In Cancer's industry is
Biotechnology Research
Australian Centre For Rna Therapeutics In Cancer's top competitors are
Mrna Core,
Rna Innovation Foundry,
Johns Hopkins Rna Innovation Center,
Lixa,
Ausel Cancer Innovation,
Australian Microbial Ecology Conference (Ausme),
Life Sciences Wa,
Mrna Victoria,
Xygene,
Graph.
Australian Centre For Rna Therapeutics In Cancer's categories are Biotechnology Research
Australian Centre For Rna Therapeutics In Cancer's founding year is 2024
